Related Experiment Video
Updated: Aug 26, 2025

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
Published on: May 11, 2018
Outcomes of pediatric patients supported with ventricular assist devices single center experience
Hsun-Yi Fu1, Heng-Wen Chou2, Chien-Heng Lai2
1Department of Cardiovascular Surgery, Department of Surgery, National Taiwan University Hospital Hsin-Chu Branch, Hsin-Chu, Taiwan.
Insights
Pediatric ventricular assist device (VAD) use is increasing. Our hospital reports favorable outcomes for pediatric VAD patients, with 72.7% achieving positive results at one month.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Surgery
- Biomedical Engineering
Background:
- Increasing use of pediatric ventricular assist devices (VADs) globally.
- Limited participation of Asian pediatric heart centers in international VAD registries.
- Need to report outcomes from non-Western centers.
Purpose of the Study:
- To report the outcomes of pediatric VAD implantation at our institution.
- To contribute data from an Asian pediatric heart center to the global understanding of VAD therapy.
- To evaluate the safety and efficacy of VADs in a pediatric population.
Main Methods:
- Retrospective analysis of all pediatric patients (<18 years) who received a VAD between 2008 and 2021.
- Data collection on patient demographics, diagnosis, VAD type, INTERMACS profile, duration on support, and outcomes.
- Analysis of survival rates, causes of death, and recovery status.
Main Results:
- 33 pediatric patients received VADs, primarily for dilated cardiomyopathy (n=16) and acute fulminant myocarditis (n=9).
- Paracorporeal continuous-flow pumps were most common (n=27), with most patients in INTERMACS profile 1 (n=24).
- Positive outcomes (alive on device, bridge to transplantation/recovery) were observed in 72.7% at 1 month, 67.7% at 3 months, and 67.7% at 6 months. Neurological complications were the leading cause of death within the first month.
Conclusions:
- Pediatric VAD implantation at our institution demonstrated favorable outcomes.
- Early VAD support can be effective for critically ill pediatric heart failure patients.
- Further research is needed to compare outcomes across different centers and VAD technologies.
Background:
There has been a remarkable increase in the number of pediatric ventricular assist device (VAD) implanted over the past decade. Asian pediatric heart centers had not participated in the multicenter registries among the Western countries. This article aimed to report the outcomes of pediatric VAD in our hospital.
Methods:
The study enrolled all patients aged <18 years at the time of VAD implantation in our institution between 2008 and 2021.
Results:
There were 33 patients with diagnosis of acute fulminant myocarditis (n = 9), congenital heart disease (n = 5), dilated cardiomyopathy (n = 16), and others. Paracorporeal continuous-flow pump was the most frequently implanted (n = 27). Most of the devices were implanted in patients with INTERMACS profile 1 (n = 24). The median duration on VAD was 22 days (range 2-254). The proportion of patients attaining positive outcomes (alive on device, bridge to transplantation or recovery) was 72.7% at 1 month, 67.7% at 3 months, and 67.7% at 6 months. Most of the deaths on device occurred within the first month post-implant (n = 9), with neurological complications being the most frequent cause of death. All recovered cases were successfully weaned off the device within the first month of implantation.
Conclusion:
We demonstrated a favorable outcome in pediatric patients supported with VAD at our institution.
More Related Videos
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Heart Failure VI: Adjunct Therapies

